XML 88 R44.htm IDEA: XBRL DOCUMENT
v3.23.2

FAIR VALUE MEASUREMENTS (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2023
Fair Value Disclosures [Abstract] |
Schedule of financial assets and liabilities measured at fair value on a recurring basis | The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2023:
(In millions) |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |  |
Money market funds |  | $ | 3,241 |  |  | $ | — |  |  | $ | — |  |  | $ | 3,241 |
Foreign currency forward contracts |  | — |  |  | 76 |  |  | — |  |  | 76 |
Cross-currency swap contracts |  | — |  |  | 22 |  |  | — |  |  | 22 |
Total |  | $ | 3,241 |  |  | $ | 98 |  |  | $ | — |  |  | $ | 3,339 |
Liabilities: |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | $ | — |  |  | $ | 49 |  |  | $ | — |  |  | $ | 49 |
Interest rate-related derivatives |  | — |  |  | 150 |  |  | — |  |  | 150 |
DECIEM stock options |  | — |  |  | — |  |  | 99 |  |  | 99 |
Total |  | $ | — |  |  | $ | 199 |  |  | $ | 99 |  |  | $ | 298 |
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2022:
(In millions) |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |  |
Money market funds |  | $ | 961 |  |  | $ | — |  |  | $ | — |  |  | $ | 961 |
Foreign currency forward contracts |  | — |  |  | 191 |  |  | — |  |  | 191 |
Interest rate-related derivatives |  | — |  |  | 24 |  |  | — |  |  | 24 |
Total |  | $ | 961 |  |  | $ | 215 |  |  | $ | — |  |  | $ | 1,176 |
Liabilities: |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | $ | — |  |  | $ | 105 |  |  | $ | — |  |  | $ | 105 |
Interest rate-related derivatives |  | — |  |  | 115 |  |  | — |  |  | 115 |
DECIEM stock options |  | — |  |  | — |  |  | 74 |  |  | 74 |
Total |  | $ | — |  |  | $ | 220 |  |  | $ | 74 |  |  | $ | 294 |
Schedule of estimated fair values of financial instruments | The estimated fair values of the Company’s financial instruments are as follows:
|  | June 30
|  | 2023 |  | 2022
(In millions) |  | Carrying Amount |  | Fair Value |  | Carrying Amount |  | Fair Value
Nonderivatives |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 4,029 |  |  | $ | 4,029 |  |  | $ | 3,957 |  |  | $ | 3,957 |
Current and long-term debt |  | 8,114 |  |  | 7,665 |  |  | 5,412 |  |  | 5,139 |
DECIEM stock options |  | 99 |  |  | 99 |  |  | 74 |  |  | 74 |
Deferred consideration payable |  | 341 |  | 338 |  | 38 |  | 38
Derivatives |  |  |  |  |  |  |  |
Cross-currency swap contracts - asset, net |  | 22 |  | 22 |  |  | — |  |  | — |
Foreign currency forward contracts – asset, net |  | 27 |  |  | 27 |  |  | 86 |  |  | 86 |
Interest rate-related derivatives – liability, net |  | (150) |  |  | (150) |  |  | (91) |  |  | (91) |
Impairment charges measured at fair value on a nonrecurring basis, classified as Level 3 | The following table presents the Company’s impairment charges for certain of its nonfinancial assets measured at fair value on a nonrecurring basis, classified as Level 3, during fiscal 2023, 2022 and 2021: Fiscal 2023
(In millions) |  | Impairment charges |  | Date of Fair Value Measurement |  | Fair Value(1)
Other intangible assets, net (trademarks) |  |  |  |  |  |
Dr.Jart+ |  | $ | 100 |  |  | November 30, 2022 |  | $ | 325 |
Too Faced |  | 86 |  |  | November 30, 2022 |  | 186 |
Smashbox |  | 21 |  |  | December 31, 2022 |  | — |
Total |  | $ | 207 |  |  |  |  | $ | 511 |
(1)See Note 6 – Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs. Fiscal 2022
(In millions) |  | Impairment charges |  | Date of Fair Value Measurement |  | Fair Value(1)
Other intangible assets, net (trademarks) |  |  |  |  |  |
GLAMGLOW |  | $ | 11 |  |  | March 31, 2022 |  | $ | — |
Dr.Jart+ |  | 230 |  |  | February 28, 2022 April 1, 2022 |  | 428 |
Total |  | $ | 241 |  |  |  |  | $ | 428 |
(1)See Note 6 – Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs. Fiscal 2021
(In millions) |  | Impairment Charges |  | Date of Fair Value Measurement |  | Fair Value(1)
Goodwill |  |  |  |  |  |
GLAMGLOW |  | $ | 54 |  |  | November 30, 2020 |  | $ | — |
BECCA(2) |  | 13 |  |  | February 28, 2021 |  | — |
Other |  | 4 |  |  | June 30, 2021 |  | — |
Total |  | 71 |  |  |  |  | — |
Other intangible assets, net (trademark and customer lists) |  |  |  |  |  |
GLAMGLOW |  | 52 |  | November 30, 2020 April 1, 2021 |  | 11 |
BECCA(2) |  | 34 |  | February 28, 2021 |  | — |
Smashbox |  | 11 |  | April 1, 2021 |  | 21 |
Total |  | 97 |  |  |  |  | 32 |
Long-lived assets |  | 71 |  |  | March 31, 2021 June 30, 2021 |  | 66 |
Total |  | $ | 239 |  |  |  |  | $ | 98 |
(1)See Note 6 – Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs. (2)See Note 8 – Charges Associated with Restructuring and Other Activities for further information relating to goodwill and other intangible asset impairment charges recorded in connection with the exit of the global distribution of BECCA products.
Changes in DECEIM stock option liability | Changes in the DECIEM stock option liability for the year ended June 30, 2023 are included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings and were as follows:
(In millions) |  | Fair Value
DECIEM stock option liability as of June 30, 2022 |  | $ | 74 |
Changes in fair value, net of foreign currency remeasurements(1) |  | 22 |
Translation adjustments and other, net |  | 3 |
DECIEM stock option liability as of June 30, 2023 |  | $ | 99 |
(1)Amount inc ludes expense attributable to graded vesting of stock opt ions which is not material for the year ended June 30, 2023.

X
- Definition Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb) -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-11 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration